{"id":605040,"date":"2026-07-23T13:30:35","date_gmt":"2026-07-23T13:30:35","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/605040\/global-life-science-instrumentation-market-projected-to-reach-9253-billion-by-2031-driven-by-automation-ai-and-rd-investments.html"},"modified":"2026-07-23T13:30:35","modified_gmt":"2026-07-23T13:30:35","slug":"global-life-science-instrumentation-market-projected-to-reach-9253-billion-by-2031-driven-by-automation-ai-and-rd-investments","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/605040\/global-life-science-instrumentation-market-projected-to-reach-9253-billion-by-2031-driven-by-automation-ai-and-rd-investments.html","title":{"rendered":"Global Life Science Instrumentation Market Projected to Reach $92.53 Billion by 2031, Driven by Automation, AI, and R&amp;D Investments"},"content":{"rendered":"<div style=\"float:right;width:250px;padding:8px 10px 10px 10px\">\n<div><a rel=\"nofollow noopener\" href=\"https:\/\/www.abnewswire.com\/upload\/2026\/07\/1784794812.jpg\" style=\"border:none !important\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Global Life Science Instrumentation Market Projected to Reach $92.53 Billion by 2031, Driven by Automation, AI, and R&amp;D Investments\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/07\/1784794812.jpg\" alt=\"Global Life Science Instrumentation Market Projected to Reach $92.53 Billion by 2031, Driven by Automation, AI, and R&amp;D Investments\" width=\"225\" height=\"88\" style=\"padding:0px 0px 10px 10px;border:0 solid !important\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) &#8211; Global Forecast to 2031 <\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify\">According to the latest comprehensive market research report published by MarketsandMarkets&trade;, the global <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/life-science-chemical-biotech-instrumentation-market-38.html?utm_source=abnewswire.com&amp;utm_medium=paidpr&amp;utm_campaign=life-science-instrumentation\">Life Science Instrumentation Market<\/a> is set to experience robust growth over the coming years. Valued at $59.91 billion in 2024 and estimated at $63.40 billion in 2025, the market is projected to reach $92.53 billion by 2031, expanding at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period from 2025 to 2031.<\/p>\n<p style=\"text-align: justify\">The global market growth is significantly propelled by rising investments in pharmaceutical and biotechnology research and development (R&amp;D), an increasing global focus on precision medicine, and expanding applications in biological, agricultural, and environmental testing.<\/p>\n<p style=\"text-align: justify\"><strong>Download PDF Brochure:<a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=38&amp;utm_source=abnewswire.com&amp;utm_medium=paidpr&amp;utm_campaign=life-science-instrumentation\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=38<\/a><\/strong><\/p>\n<p style=\"text-align: justify\"><strong>Key Market Highlights &amp; Drivers<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p class=\"caps\">Surging Pharmaceutical &amp; Biotech R&amp;D: Multinational pharmaceutical and biotechnology firms are significantly expanding their manufacturing capacities and drug pipelines. Recent strategic capital investments&mdash;such as Merck&rsquo;s $3 billion Center of Excellence construction in Elkton, Virginia, and AbbVie&rsquo;s $1.4 billion R&amp;D and manufacturing facility commitment&mdash;highlight the intense demand for high-throughput screening, mass spectrometry, and automated molecular analysis systems.<\/p>\n<\/li>\n<li>\n<p>Rapid Technological Transformation: Laboratory workflows are undergoing a major shift toward digitalization, laboratory automation, and AI-driven data integration. Next-generation analytical devices are increasingly leveraging built-in diagnostic tools, automated troubleshooting, and remote alerts to lower downtime and increase precision.<\/p>\n<\/li>\n<li>\n<p>Expanding Service Organizations: The rapid growth of Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), and Contract Testing Laboratories (CTLs) is creating substantial opportunities for instrument manufacturers. These service providers require scalable, high-throughput, and regulatory-compliant instruments to accelerate drug discovery timelines.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong>Market Segmentation DynamicsBy Technology:<\/strong><\/p>\n<p style=\"text-align: justify\">Spectroscopy, chromatography, and molecular testing systems continue to drive high analytical adoption across laboratories. Advanced analytical tools&mdash;including high-resolution detectors, mass spectrometers, and next-generation sequencing (NGS) platforms&mdash;are increasingly essential for genomics and proteomics research. While specialized technologies hold dominant individual market shares, integrated analytical workflows remain a core focus for research and industrial institutions.<\/p>\n<p style=\"text-align: justify\"><strong>By Application:<\/strong><\/p>\n<p style=\"text-align: justify\">Research Applications held the largest share of the market, accounting for 63.8% in 2025. The demand in this segment is reinforced by public and private funding for disease research, biotherapeutic development, and biomarker identification. Clinical and diagnostic applications as well as industrial manufacturing applications also remain pivotal growth sectors.<\/p>\n<p style=\"text-align: justify\"><strong>By End User:<\/strong><\/p>\n<p style=\"text-align: justify\">While pharmaceutical and biotechnology companies represent the largest overall customer base for advanced instrumentation, the Agriculture and Food Industries segment is projected to register the fastest growth, with a CAGR of 7.7% between 2025 and 2031. This expansion is largely fueled by heightened global focus on food safety, contaminant testing, and stringent regulatory compliance.<\/p>\n<p style=\"text-align: justify\"><strong>Regional Outlook: Asia Pacific Leads Growth<\/strong><\/p>\n<p style=\"text-align: justify\">While North America and Europe maintain strong positions due to established biomedical infrastructures, the Asia Pacific region is poised to be the fastest-growing market, expecting a CAGR of 7.3% during the forecast period.<\/p>\n<p style=\"text-align: justify\">Key drivers in Asia Pacific include expanding pharmaceutical and biopharmaceutical manufacturing hubs across China, India, Japan, and South Korea, coupled with government initiatives supporting life science infrastructure and an increasing volume of outsourced clinical research activities.<\/p>\n<p style=\"text-align: justify\"><strong>Competitive Landscape &amp; Strategic Developments<\/strong><\/p>\n<p style=\"text-align: justify\">Leading industry players are heavily prioritizing R&amp;D investments, key strategic partnerships, and targeted acquisitions to expand their analytical portfolios and global footprint. Prominent market participants include:<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>Thermo Fisher Scientific Inc. (US)<\/p>\n<\/li>\n<li>\n<p>Agilent Technologies Inc. (US)<\/p>\n<\/li>\n<li>\n<p>Shimadzu Corporation (Japan)<\/p>\n<\/li>\n<li>\n<p>Danaher Corporation (US)<\/p>\n<\/li>\n<li>\n<p>Waters Corporation (US)<\/p>\n<\/li>\n<li>\n<p>Becton, Dickinson and Company (US)<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\">Recent strategic maneuvers illustrate this aggressive development strategy. For instance, Agilent Technologies announced a $950 million acquisition of Biocare Medical to bolster its oncology diagnostics portfolio and launched its Infinity III LC Series featuring AI-assisted troubleshooting. Similarly, Waters Corporation recently debuted its Xevo Charge Detection Mass Spectrometer (CDMS) aimed at large biomolecule characterization for cell and gene therapies.<\/p>\n<p style=\"text-align: justify\"><strong>Request Sample Pages-<a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=38&amp;utm_source=abnewswire.com&amp;utm_medium=paidpr&amp;utm_campaign=life-science-instrumentation\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=38<\/a><\/strong><\/p>\n<p style=\"text-align: justify\"><strong>Industry Restraints and Challenges<\/strong><\/p>\n<p style=\"text-align: justify\">Despite strong market projections, high capital costs associated with premium, high-end analytical equipment remain a key restraint, particularly for smaller academic institutions and labs in emerging economies. Additionally, a persistent global shortage of skilled technical professionals capable of operating complex high-throughput systems, alongside data privacy concerns surrounding NGS cloud software, pose ongoing operational challenges.<\/p>\n<p><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=global-life-science-instrumentation-market-projected-to-reach-9253-billion-by-2031-driven-by-automation-ai-and-rd-investments\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/www.marketsandmarkets.com\" target=\"_blank\">https:\/\/www.marketsandmarkets.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=global-life-science-instrumentation-market-projected-to-reach-9253-billion-by-2031-driven-by-automation-ai-and-rd-investments\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) &#8211; Global Forecast to 2031 According<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/605040"}],"collection":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/comments?post=605040"}],"version-history":[{"count":0,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/605040\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/media?parent=605040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/categories?post=605040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/tags?post=605040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}